These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549 [TBL] [Abstract][Full Text] [Related]
28. Glycopeptide and oxacillin activity against Staphylococcus aureus isolates at a tertiary care center in Lebanon. Kanj SS; Ghaleb PA; Araj GF J Med Liban; 2004; 52(1):8-12. PubMed ID: 15881695 [TBL] [Abstract][Full Text] [Related]
29. Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan. Huang YT; Liao CH; Teng LJ; Hsueh PR Clin Microbiol Infect; 2008 Feb; 14(2):124-9. PubMed ID: 18076671 [TBL] [Abstract][Full Text] [Related]
30. Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies. Pankuch GA; Lin G; Hoellman DB; Good CE; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 2006 May; 50(5):1727-30. PubMed ID: 16641442 [TBL] [Abstract][Full Text] [Related]
32. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models. Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162 [TBL] [Abstract][Full Text] [Related]
33. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers. Jones RN; Barry AL; Gardiner RV; Packer RR Diagn Microbiol Infect Dis; 1989; 12(5):385-94. PubMed ID: 2533050 [TBL] [Abstract][Full Text] [Related]
35. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus. Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396 [TBL] [Abstract][Full Text] [Related]
36. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study]. Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs. Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815 [TBL] [Abstract][Full Text] [Related]
38. In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Pistella E; Falcone M; Baiocchi P; Pompeo ME; Pierciaccante A; Penni A; Venditti M Infez Med; 2005 Jun; 13(2):97-102. PubMed ID: 16220029 [TBL] [Abstract][Full Text] [Related]
39. Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance. Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López-Fabal F; Gómez M; Diagn Microbiol Infect Dis; 2011 Jul; 70(3):373-9. PubMed ID: 21683269 [TBL] [Abstract][Full Text] [Related]
40. In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus. Guenthner SH; Wenzel RP Antimicrob Agents Chemother; 1984 Aug; 26(2):268-9. PubMed ID: 6237606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]